News

Adalimumab Promoted Mucosal Healing in Crohn's Disease

Publish date: April 12, 2012

 

FROM GASTROENTEROLOGY

This study was sponsored by Abbott Laboratories, maker of adalimumab. Dr. Rutgeerts and his associates reported numerous ties to industry sources.

Pages

Recommended Reading

Two More Pancreatic Enzymes Approved by FDA
MDedge Family Medicine
C. difficile Infections Hit All-Time High
MDedge Family Medicine
Medical Management Effective for Intra-Abdominal Abscesses
MDedge Family Medicine
Hepatitis C Infection Increasing Among Adolescents, Young Adults
MDedge Family Medicine
Children Most Vulnerable to Breakthrough Hepatitis B Identified
MDedge Family Medicine
Anesthesia Services for GI Procedures Have Doubled
MDedge Family Medicine
Gastroenteritis Deaths Soar, Largely Due to C. difficile, Norovirus
MDedge Family Medicine
Risk Factors for C. difficile Recurrence Identified
MDedge Family Medicine
Most People Told to Have a Colonoscopy Don't
MDedge Family Medicine
What’s best for IBS?
MDedge Family Medicine